ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 71 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $154,000 | -48.1% | 62,873 | 0.0% | 0.00% | – |
| Q4 2019 | $297,000 | +40.1% | 62,873 | +26.7% | 0.00% | – |
| Q3 2019 | $212,000 | +42.3% | 49,619 | +147.1% | 0.00% | – |
| Q1 2016 | $149,000 | -77.8% | 20,079 | -75.1% | 0.00% | -100.0% |
| Q4 2015 | $671,000 | -32.2% | 80,793 | -26.5% | 0.00% | -50.0% |
| Q3 2015 | $990,000 | -40.5% | 109,926 | -20.8% | 0.00% | -33.3% |
| Q2 2015 | $1,665,000 | +160.2% | 138,758 | +133.6% | 0.00% | +200.0% |
| Q1 2015 | $640,000 | +91.0% | 59,400 | -53.2% | 0.00% | 0.0% |
| Q3 2014 | $335,000 | -33.4% | 127,000 | +1.7% | 0.00% | 0.0% |
| Q2 2014 | $503,000 | +305.6% | 124,900 | +362.6% | 0.00% | – |
| Q1 2014 | $124,000 | +5.1% | 27,000 | -1.1% | 0.00% | – |
| Q4 2013 | $118,000 | +9.3% | 27,300 | 0.0% | 0.00% | – |
| Q3 2013 | $108,000 | +89.5% | 27,300 | 0.0% | 0.00% | – |
| Q2 2013 | $57,000 | -50.0% | 27,300 | 0.0% | 0.00% | – |
| Q4 2012 | $114,000 | – | 27,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |